Evidence map›Paper›PMID 23279830›Full record

ArticleIranian biomedical journal2013

Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.

Reza Yadegarazari, Taghi Hassanzadeh, Amir Majlesi, Amir Keshvari, Alireza Monsef Esfahani, Amirsasan Tootoonchi, Nooshin Shabab, Massoud Saidijam

Open access · goldAbstract read
In one paragraph

Article in Iranian biomedical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Reza YadegarazariResearch Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Taghi HassanzadehResearch Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Amir MajlesiDept. of Gastrointestinal Disease, Beheshti Hospital of Hamadan University of Medical Sciences, Hamadan, Iran.
Amir KeshvariDept. of General Surgery, Imam Khomeini Hospital of Tehran University of Medical Sciences, Tehran, Iran.
Alireza Monsef EsfahaniDept. of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran.
Amirsasan TootoonchiResearch Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Nooshin ShababResearch Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Massoud SaidijamResearch Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEfficient screening for detection of colorectal cancer (CRC) at earlier stages reduces its mortality. The purpose of this study was to investigate expression of carcinoembryonic antigen (CEA) and human telomerase reverse transcriptase (hTERT) mRNA in peripheral blood of CRC patients and to present strategies for early detection screen test.

methodsTwenty seven patients in non-metastatic stage and 27 healthy individuals were studied. Expression of CEA, hTERT mRNA and 18srRNA (18s subunit of ribosomal RNA, as reference gene) were determined based on real-time RT-PCR on 3 µg of total RNA from blood in 3 separate vials (1 µg per vial).

resultsPositive expression rate of CEA mRNA (78%) and hTERT mRNA (81%) were higher in patient group (P<0.001). These rates were meaningfully higher than the results of individual vials containing only 1 µg of total RNA. Difference between Ct values of markers with 18srRNA ΔCt) was higher in healthy group than patient one. Therefore, a ΔCt cut-off value was determined for distinguishing between true- and false-positive results. Concurrent expression of both markers was found in 67% of the patients, which was higher than healthy cases (11%). Combination of concurrent marker expression with cut-off point strategy increased specificity to 100%.

conclusionThese results showed that concurrent evaluation of marker expression and performing the test on 3 µg of samples in 3 separate vials may increase specificity and sensitivity of real-time RT-PCR for early detection of non-metastatic CRC. However, more investigations with larger numbers of samples are needed to verify these results.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorCarcinoembryonic AntigenColorectal NeoplasmsEarly Detection of CancerFemaleHumansMaleMiddle AgedPilot ProjectsReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, Ribosomal, 18STelomeraseBiomarkers, TumorCarcinoembryonic AntigenRNA, MessengerRNA, Ribosomal, 18STelomeraseTERT protein, humanBiomarkerCarcinoembryonic antigenColorectal cancer

Identifiers

PMID23279830
PMCPMC3600971
OpenAlexW2103245492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.